Spending it while we got it, and the FDA slaps down Cheerios
Good day for living for the moment, Bad day for Cheerios
GOOD DAY FOR: Living for the moment, as more and more U.S. consumers are thawing their spending freeze amid signs that the economy is stabilizing—and to celebrate such things as surviving a round of layoffs. April saw the largest jump in consumer confidence in two years, and many economists see personal consumption starting to rise in July. (Bloomberg) Not yet, though. The Commerce Department reported that retail sales fell for a second straight month in April. (Reuters)
BAD DAY FOR: Cheerios, after the Food and Drug Administration ordered General Mills to stop claiming that the breakfast cereal can reduce cholesterol levels by 4 percent in six weeks. The FDA didn’t dispute the claim, but said that only drugs can list specific, measurable health benefits. If Cheerios wants to market itself as a cholesterol aid, it can submit its research to the FDA for rigorous scientific scrutiny. (The Washington Post)
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
10 concert tours to see this upcoming fall
The Week Recommends Get ready for pumpkin spice season with concerts from big-name artists
-
How to put student loan payments on pause
The Explainer If you are starting to worry about missing payments, deferment and forbearance can help
-
Is Kash Patel’s fate sealed after Kirk shooting missteps?
TODAY'S BIG QUESTION The FBI’s bungled response in the immediate aftermath of the Charlie Kirk shooting has director Kash Patel in the hot seat